SWK Holdings Co. 9.00% Senior Notes due 2027 (NASDAQ:SWKHL) Sees Significant Decline in Short Interest

SWK Holdings Co. 9.00% Senior Notes due 2027 (NASDAQ:SWKHL) was the target of a large decline in short interest in September. As of September 30th, there was short interest totaling 48 shares, a decline of 97.5% from the September 15th total of 1,940 shares. Based on an average daily volume of 7,045 shares, the days-to-cover ratio is presently 0.0 days.

SWK Holdings Co. 9.00% Senior Notes due 2027 Trading Up 0.0%

Shares of SWK Holdings Co. 9.00% Senior Notes due 2027 stock traded up $0.01 during trading on Friday, reaching $25.08. 2,039 shares of the stock traded hands, compared to its average volume of 3,735. The business has a fifty day simple moving average of $25.30 and a two-hundred day simple moving average of $25.35. SWK Holdings Co. 9.00% Senior Notes due 2027 has a 52-week low of $24.34 and a 52-week high of $25.92.

SWK Holdings Co. 9.00% Senior Notes due 2027 Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th were paid a dividend of $0.5625 per share. The ex-dividend date of this dividend was Tuesday, September 15th. This represents a $2.25 dividend on an annualized basis and a yield of 9.0%.

SWK Holdings Corporation is a specialty finance company focused on the healthcare and life sciences industries. The company provides capital to businesses developing and commercializing pharmaceuticals, biotechnology products, medical devices, diagnostics and other healthcare technologies.

Its financing activities may include structured debt, royalty monetization and other customized funding arrangements designed to provide non-dilutive or flexible capital to healthcare companies. SWK Holdings generally seeks opportunities where its financing can support product development, commercialization and business growth.

Founded in 2006 and headquartered in Dallas, Texas, SWK Holdings has invested in healthcare businesses and intellectual property across the United States and other markets.